Chronicle AM: DE Legalization Bill Advances, Opioid Maker InSys Pays Out Big Time, More… (6/6/19)

Delaware could be the next state to legalize marijuana if it hurries, Brazil's rightist president approves regressive new drug laws, Colombia's disarmed FARC rebels are starting to pick up their guns again, an opioid manufacturer pays out bigtime for bribing doctors to prescribe its fentanyl product, and more.

Marijuana Policy

Delaware Marijuana Legalization Bill Heads for House Floor Vote.The House Revenue and Finance Committee has approved a marijuana legalization bill, HB 110, on Wednesday. The measure now heads for a House floor vote. The bill would establish a state-licensed industry but would bar home cultivation. The bill calls for the state to collect a 15% tax on retail sales price of marijuana, as well as licensing fees. The legislative session ends June 30.

Maine Regulators Adopt Provisional Rules, Send Them to Legislature. Nearly three years after residents voted to legalize marijuana, the state Office of Marijuana Policy has released draft rules, which are now up for review by the legislature. This is the third attempt to get rules adopted to allow the state to get its marijuana industry going. The first two were vetoed by then Gov. Paul LePage (R).

Medical Marijuana

Louisiana House Approves Allowing Patients to Inhale, But Not Smoke. The House voted unanimously to approve HB 358, which would allow patients to inhale — but not smoke — their medicine. The bill had stalled in the Senate, but was revived after legislators included a "metered-dose inhaler" in the definition of acceptable devices. The measure now goes to the governor's desk.

Heroin and Prescription Opioids

InSys Therapeutics to Pay $225 Million for Bribing Docs to Prescribe Its Fentanyl Product. Opioid manufacturer Insys Therapeutics has agreed to pay $225 million to end civil and criminal investigations into charges it used bribery to get doctors to illegally prescribe its highly addictive fentanyl spray, Subsys. The company also agreed to plead guilty to five counts of mail fraud and admitted that its speaker program "to increase brand awareness" was actually "a vehicle to pay bribes and kickbacks to targeted practitioners."

Harm Reduction

Philadelphia Study Finds Community Support for Safe Injection Site. A Drexel University study published Thursday finds that a majority of residents and business owners in the city's Kensington neighborhood support opening a safe injection site there. The Philadelphia-based nonprofit Safehouse is working toward getting one open in the neighborhood. "We're vindicated that the people who are most affected believe that it’s needed," said Ronda Goldfein, Safehouse vice president and secretary and executive director of the AIDS Law Project of Pennsylvania. "We recognize that we need multiple sites, but let's be realistic that we need to put our first site where the need is greatest."

International

Brazil's Bolsonaro Approves Regressive Drug Policy Changes. Brazil's ultra-rightist President Jair Bolsonaro has approved drug legislation passed earlier this year that toughens penalties for drug traffickers and requires drug users to undergo drug treatment at private or religious centers.

Colombia's Disarmed FARC Rebels Are Picking Up Their Guns Again. As many as a third of fighters in the FARC, which disbanded following a 2016 peace agreement, have taken up arms again, according to a military intelligence report. More than 2,000 of the FARC's 6,000 fighters have joined dissident FARC groups, many of which are operating in coca-growing regions. That's up a dramatic 30% since December. Disarmed FARC rebels were supposed to have been reintegrated into society, but that has been stymied by violence and discrimination. At least 139 former FARC members have been killed since disarming. "It doesn't help the government's case for reinsertion that many of the productive projects are failing to take off, their former comrades continue to be stigmatized by the ruling party, and a record number of killings of former FARC members remains uninvestigated and unpunished," Sergio Guzmán, director of Colombia Risk Analysis said.